Ademi LLP Probes Theravance Biopharma-Zymeworks Deal Over Fair-Price Concerns
Milwaukee-based law firm Ademi LLP has opened an investigation into Theravance Biopharma, Inc. (NASDAQ: TBPH) over its recently announced transaction with Zymeworks, examining whether the deal adequately compensates…
Filed via prnewswire.com